Zynex Inc. (NYSE:ZYXI) reached a new 52-week high on Monday . The stock traded as high as $27.54 and last traded at $26.81, with a volume of 132495 shares trading hands. The stock had previously closed at $25.12.
Separately, HC Wainwright lowered Zynex from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 19th.
The firm has a 50-day moving average of $21.89 and a 200 day moving average of $14.28.
Zynex (NYSE:ZYXI) last released its quarterly earnings results on Tuesday, April 28th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.07 by $0.02. The company had revenue of $15.23 million for the quarter, compared to analyst estimates of $15.07 million.
Zynex Company Profile (NYSE:ZYXI)
Zynex, Inc, through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device.
Further Reading: Oversold
Receive News & Ratings for Zynex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zynex and related companies with MarketBeat.com's FREE daily email newsletter.